Literature DB >> 4537849

Hereditary crystalline stromal dystrophy of Schnyder. I. Clinical features of a family with hyperlipoproteinaemia.

A J Bron, H P Williams, M E Carruthers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4537849      PMCID： PMC1215389          DOI： 10.1136/bjo.56.5.383

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  16 in total

1.  [ASSOCIATION IN THE SAME FAMILY OF A COLOBOMA OF THE CRYSTALLINE LENS AND MARFAN'S SYNDROME].

Authors:  L PAUFIQUE; M P RAVAULT; M BONNET
Journal:  Bull Soc Ophtalmol Fr       Date:  1964-01

2.  [Frequency curves of several frequent congenital or senile alterations of the anterior chamber as a function of aging].

Authors:  F MARTY
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1957 Jan-Feb

3.  Hereditary crystalline degeneration of the cornea.

Authors:  J L MALBRAN; J M PAUNESSA; F VIDAL
Journal:  Ophthalmologica       Date:  1953-12       Impact factor: 3.250

4.  Crystalline Dystrophy of the Cornea.

Authors:  W E Fry; W E Pickett
Journal:  Trans Am Ophthalmol Soc       Date:  1950

5.  Lipaemia of the limbal vessels.

Authors:  A J Bron; H P Williams
Journal:  Br J Ophthalmol       Date:  1972-04       Impact factor: 4.638

6.  Central crystalline corneal dystrophy.

Authors:  A G Karseras; D C Price
Journal:  Br J Ophthalmol       Date:  1970-10       Impact factor: 4.638

7.  [Schnyder's hereditary crystalline degeneration of the cornea].

Authors:  J Svĕrák; S Kindernay
Journal:  Cesk Oftalmol       Date:  1969-09

Review 8.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

9.  Ocular manifestations of hyperlipoproteinemia.

Authors:  P F Vinger; B A Sachs
Journal:  Am J Ophthalmol       Date:  1970-10       Impact factor: 5.258

10.  Familial plasma lecithin: cholesterol acyltransferase deficiency.

Authors:  B Hamnström; E Gjone; K R Norum
Journal:  Br Med J       Date:  1969-05-03
View more
  15 in total

1.  Hereditary crystalline stromal dystrophy of Schnyder. II. Histopathology and ultrastructure.

Authors:  A Garner; R C Tripathi
Journal:  Br J Ophthalmol       Date:  1972-05       Impact factor: 4.638

2.  Lipaemia of the limbal vessels.

Authors:  A J Bron; H P Williams
Journal:  Br J Ophthalmol       Date:  1972-04       Impact factor: 4.638

3.  Tay-Sachs' disease and Fabry's disease: clinical and chemical diagnosis of two metabolic eye diseases.

Authors:  E Cotlier
Journal:  Bull N Y Acad Med       Date:  1974 Jul-Aug

4.  [Schnyder's corneal dystrophy and hyperlipidemia (author's transl].

Authors:  R Kaden; G Feurle
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-02-04

Review 5.  Bilateral, anterior stromal ring opacity of the cornea.

Authors:  G R Melles; J P de Séra; C A Eggink; J R Cruysberg; P S Binder
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

6.  Cholesterol turnover in hereditary crystalline corneal dystrophy of Schnyder.

Authors:  R P Burns; W Connor; I Gipson
Journal:  Trans Am Ophthalmol Soc       Date:  1978

7.  Crystalline stromal dystrophy: histochemistry and ultrastructure of the cornea.

Authors:  R O Weller; F C Rodger
Journal:  Br J Ophthalmol       Date:  1980-01       Impact factor: 4.638

8.  Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis).

Authors:  Jayne S Weiss
Journal:  Trans Am Ophthalmol Soc       Date:  2007

9.  Quantitative analysis of lipid deposits from Schnyder's corneal dystrophy.

Authors:  M Yamada; H Mochizuki; Y Kamata; Y Nakamura; Y Mashima
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

10.  A mutation in the UBIAD1 gene in a Han Chinese family with Schnyder corneal dystrophy.

Authors:  Chunyu Du; Ying Li; Lili Dai; Lingmin Gong; Chengcheng Han
Journal:  Mol Vis       Date:  2011-10-15       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.